← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

▼ SELL 10b5-1 Plan

$ Value

$1.4M

Shares

37,255

Price

$39

Filed

Oct 22

Insider

Name

Megna Michael R

Title

CHIEF ACCOUNTING OFFICER

CIK

0001464583

Roles

Officer

Transaction Details

Transaction Date

2025-10-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,281

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.145 and $39.57. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001464583-25-000005

Form Type

4

Issuer CIK

0001730430

Megna Michael R's History

Date Ticker Type Value
2026-04-09 KNSA $309K
2026-04-07 KNSA M $4K
2026-04-07 KNSA F $82K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $154K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07